emi-137
Small moleculeexperimental
Clinical trial activity
3 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Feb 9, 2017 (NCT03205501)
Timeline
Indications
Mechanism of action
- Hepatocyte growth factor receptorINHIBITOR
MET inhibitor
Chemistry & pharmacology
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL4297745 ↗
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03470259 | Phase 1 | Jun 20, 2018 | University of Groningen, Utrecht University |
| NCT03360461 | Phase 2 | Feb 14, 2018 | Edinburgh Molecular Imaging Ltd, University of Leeds |
| NCT03205501 | Phase 1 | Feb 9, 2017 | University of Groningen |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| University of Groningen | Academic/Hospital | 2 | 2 | 1 | 2017 |
| Edinburgh Molecular Imaging Ltd | For profit | 1 | 0 | 1 | 2018 |
| University of Leeds | Academic/Hospital | 1 | 1 | 1 | 2018 |
| Utrecht University | Academic/Hospital | 1 | 0 | 1 | 2018 |
4 organizations
Page 1 / 1